Listen "API-CAT & IMPROVE"
Episode Synopsis
We discuss reduced dose apixaban for months 6+ of treating cancer-associated VTE (API-CAT) and the impact (or lack thereof) of pausing BTK-inhibitors around vaccination (IMPROVE)
More episodes of the podcast OncoPharm
Iberdomide
20/08/2026
Kidney Cancer in a Nutshell
13/08/2026
Small Cell Lung Cancer and CINV Updates
06/08/2026
Zidesamtinib & PPIs in Pacific
30/07/2026
Gedatolisib et al
23/07/2026
Endurance Part 2
16/07/2026
A Decade of CAR-T, Ocra-T, & POLARGO
09/07/2026
Breast Cancer Updates and T-Cell Stemness
25/06/2026
ASCO '26
11/06/2026
